Skip to content

Clinical trials

Phase 1 Adenocarcinoma of Lung trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma of Lung Phase: Phase 1 Country / region: United States Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20022
20031
20045
20051
20062
20071
20081
20092
20121
20132
20142
20151
20161
20172
20191
20205
20231
20242
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated9
Recruiting5
Active, not recruiting3
Unknown status2
Withdrawn2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Roswell Park Cancer Institute5
Memorial Sloan Kettering Cancer Center3
National Cancer Institute (NCI)3
Ikena Oncology2
Jonsson Comprehensive Cancer Center2
Novartis Pharmaceuticals2
University of Pennsylvania2
University of Texas Southwestern Medical Center2
University of Washington2
Alliance for Clinical Trials in Oncology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma of Lung46
Carcinoma, Non-Small-Cell Lung31
Lung Neoplasms25
Adenocarcinoma, Bronchiolo-Alveolar11
Breast Neoplasms8
Neoplasms7
Ovarian Neoplasms6
Carcinoma, Renal Cell5
Colorectal Neoplasms5
Melanoma5

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.